RETRACTED: In vitro regulation of corticotropin-releasing hormone (Retracted Article)

被引:15
作者
Kasckow, JW [1 ]
Aguilera, G
Mulchahey, JJ
Sheriff, S
Herma, JP
机构
[1] VAMC, Psychiat Serv 116A, 3200 Vine St, Cincinnati, OH 45220 USA
[2] Univ Cincinnati, Sch Med, Dept Psychiat, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Program Neurosci, Cincinnati, OH 45267 USA
[4] NICHHD, Dev Endocrinol Branch, Sect Endocrine Physiol, NIH, Bethesda, MD 20892 USA
[5] Phase 2 Discovery Inc, Cincinnati, OH 45219 USA
[6] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA
关键词
corticotropin-releasing hormone; in vitro; culture; amygdala; hypothalamus; stress;
D O I
10.1016/S0024-3205(03)00409-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Studies involving regulation of corticotropin-releasing hormone (CRH) in vitro have been used to validate findings obtained in vivo and more importantly have been used as model systems to better understand signalling mechanisms responsible for the expression of the CRH gene and peptide. Many in vitro studies examining CRH have utilized hypothalamic tissue while a few have focused on the amygdala. Clonal cell lines have also been utilized as models of central nervous system CRH neurons. Stimuli that have been implicated in regulating hypothalamic CRH regulation in vitro include protein kinase A (PKA) and protein kinase C (PKC) activators, glucocorticoids, biogenic amines, cytokines and the gaseous neurotransmitters. Amygdalar CRH levels in vitro are affected by some of the same stimuli that regulate hypothalamic CRH; however there is evidence supporting differential regulation of CRH in these two brain regions by some of the same stimuli. Only a few studies in aggregate have investigated signal transduction mechanisms and these studies have focused on PKA- and glucocorticoid-mediated changes in CRH expression. Thus, much more investigative work in better understanding CRH regulation in vitro is needed. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:769 / 781
页数:13
相关论文
共 83 条
[1]  
ADLER GK, 1988, J BIOL CHEM, V263, P5846
[2]   PROTEIN-KINASE-C ACTIVATION INCREASES THE QUANTITY AND POLY(A) TAIL LENGTH OF CORTICOTROPIN-RELEASING HORMONE MESSENGER-RNA IN NPLC CELLS [J].
ADLER, GK ;
ROSEN, LB ;
FIANDACA, MJ ;
MAJZOUB, JA .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (03) :476-484
[3]   REGULATION OF THE MESSENGER RIBONUCLEIC-ACID FOR CORTICOTROPIN-RELEASING FACTOR IN THE PARAVENTRICULAR NUCLEUS AND OTHER BRAIN SITES OF THE RAT [J].
BEYER, HS ;
MATTA, SG ;
SHARP, BM .
ENDOCRINOLOGY, 1988, 123 (04) :2117-2122
[4]  
BUZETTI R, 1988, J ENDOCRINOL S, V119, P95
[5]   EFFECT OF CHOLINERGIC AGONISTS AND ANTAGONISTS ON RAT HYPOTHALAMIC CORTICOTROPIN-RELEASING HORMONE-SECRETION INVITRO [J].
CALOGERO, AE ;
GALLUCCI, WT ;
BERNARDINI, R ;
SAOUTIS, C ;
GOLD, PW ;
CHROUSOS, GP .
NEUROENDOCRINOLOGY, 1988, 47 (04) :303-308
[6]   THE MUSCARINIC CHOLINERGIC AGONIST ARECOLINE STIMULATES THE RAT HYPOTHALAMIC-PITUITARY-ADRENAL AXIS THROUGH A CENTRALLY-MEDIATED CORTICOTROPIN-RELEASING HORMONE-DEPENDENT MECHANISM [J].
CALOGERO, AE ;
KAMILARIS, TC ;
GOMEZ, MT ;
JOHNSON, EO ;
TARTAGLIA, ME ;
GOLD, PW ;
CHROUSOS, GP .
ENDOCRINOLOGY, 1989, 125 (05) :2445-2453
[7]   INTERLEUKIN-2 INDUCES CORTICOTROPIN-RELEASING HORMONE-RELEASE FROM SUPERFUSED RAT HYPOTHALAMI - INFLUENCE OF GLUCOCORTICOIDS [J].
CAMBRONERO, JC ;
RIVAS, FJ ;
BORRELL, J ;
GUAZA, C .
ENDOCRINOLOGY, 1992, 131 (02) :677-683
[8]  
CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294
[9]   ENDOGENOUS SUBSTANCE-P INHIBITS THE DEPRESSION OF CORTICOTROPIN-RELEASING HORMONE DURING A CHRONIC INFLAMMATORY STRESS [J].
CHOWDREY, HS ;
LARSEN, PJ ;
HARBUZ, MS ;
LIGHTMAN, SL ;
JESSOP, DS .
LIFE SCIENCES, 1995, 57 (22) :2021-2029
[10]   Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms [J].
Clauw, DJ ;
Chrousos, GP .
NEUROIMMUNOMODULATION, 1997, 4 (03) :134-153